Literature DB >> 25756401

An organizational guideline for gynecologic oncology services.

Michael Fung-Kee-Fung1, Erin B Kennedy, Jim Biagi, Terry Colgan, David D'Souza, Laurie M Elit, Amber Hunter, Jonathan Irish, Robin McLeod, Barry Rosen.   

Abstract

OBJECTIVES: Documented variations in practice compelled the need to establish a network that would facilitate the flow of patients through the care continuum of a provincial health care system in accordance with best practices. Therefore, a guideline was developed to provide recommendations for the optimal organization of gynecologic oncology services in this higher resource location to improve access to multidisciplinary care and appropriate treatment.
METHODS: A systematic review was conducted of Web sites of international guideline developers, relevant cancer agencies, and Medline and EMBASE from 1996 to 2011 using search terms related to gynecologic malignancies, combined with organization of services, patterns of care, and various facility and physician characteristics. The results of the review were combined with expert consensus and stakeholder consultation to develop a gynecologic oncology services organizational guideline.
RESULTS: The evidence review yielded a lower quality evidence base; therefore, recommendations were determined through consensus, including guidance for physician and hospital specialization, and other domains including human and physical resources. Definitive surgical treatment of most invasive cancers by subspecialist gynecologic oncologists is recommended. In addition, it is recommended that these subspecialists provide care within designated gynecologic oncology centers. The recommendations also outline which services, such as radiation therapy, may be provided in other affiliated centers. Multidisciplinary team management is also endorsed.
CONCLUSIONS: These recommendations are intended to allow a collaborative community of practice, supported by formal interorganizational processes, to evolve to facilitate adherence to guidelines and best practices at a system-wide level.

Entities:  

Mesh:

Year:  2015        PMID: 25756401     DOI: 10.1097/IGC.0000000000000400

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Follow-up of patients who are clinically disease-free after primary treatment for fallopian tube, primary peritoneal, or epithelial ovarian cancer: a Program in Evidence-Based Care guideline adaptation.

Authors:  T Le; E B Kennedy; J Dodge; L Elit
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

Review 2.  The optimal organization of gynecologic oncology services: a systematic review.

Authors:  M Fung-Kee-Fung; E B Kennedy; J Biagi; T Colgan; D D'Souza; L M Elit; A Hunter; J Irish; R McLeod; B Rosen
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

3.  Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation.

Authors:  Kahren M White; Holly Seale; Reema Harrison
Journal:  BMC Public Health       Date:  2019-03-12       Impact factor: 3.295

4.  Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario.

Authors:  Shiru L Liu; Wing C Chan; Geneviève Bouchard-Fortier; Stephanie Lheureux; Sarah E Ferguson; Monika K Krzyzanowska
Journal:  Curr Oncol       Date:  2022-08-22       Impact factor: 3.109

Review 5.  The Relevance of Gynecologic Oncologists to Provide High-Quality of Care to Women with Gynecological Cancer.

Authors:  Lucas Minig; Pablo Padilla-Iserte; Cristina Zorrero
Journal:  Front Oncol       Date:  2016-01-14       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.